iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.400
+0.010 (0.72%)
At close: Jul 31, 2026, 4:00 PM EDT
1.387
-0.013 (-0.91%)
After-hours: Jul 31, 2026, 4:57 PM EDT

iBio, Inc. Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
7015181257329
Market Cap Growth
528.75%-18.85%46.87%-78.16%-82.76%5.80%
Enterprise Value
-1.189.768.8125.5648.97264.72
Last Close Price
1.400.762.1112.20130.00755.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
237.6336.9180.87-30.11138.76
PB Ratio
0.620.990.850.810.893.03
P/TBV Ratio
1.321.000.510.750.972.74

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
-24.3939.16-25.99111.65

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.020.150.171.080.060.15
Net Debt / Equity Ratio
-0.93-0.34-0.440.86-0.12-0.59
Net Debt / EBITDA Ratio
2.600.290.61-0.470.302.24
Net Debt / FCF Ratio
3.270.330.51-0.360.171.84
Asset Turnover
0.000.020.0100.020.02
Inventory Turnover
----03.54
Quick Ratio
11.501.423.890.231.3015.43
Current Ratio
11.881.594.081.191.4815.74
Return on Equity (ROE)
-7.70%-101.52%-84.15%-74.33%-21.03%-14.05%
Return on Assets (ROA)
-38.55%-71.66%-47.57%-41.74%-24.11%-25.80%
Return on Invested Capital (ROIC)
-509.08%-170.60%-82.16%-69.63%-28.47%-25.51%
Return on Capital Employed (ROCE)
-42.02%-88.64%-75.62%-66.64%-28.38%-27.14%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Buyback Yield / Dilution
-688.29%-174.05%-525.98%-40.35%-11.45%-211.53%
Total Shareholder Return
-688.29%-174.05%-525.98%-40.35%-11.45%-211.53%
SEC Filings: 10-K · 10-Q